International Patent: MEK IMMUNE ONCOLOGY INHIBITORS AND THERAPEUTIC USES THEREOF

GENEVA, July 9 -- IMMUNEERING CORPORATION filed a patent application (US2026/010153) for “MEK IMMUNE ONCOLOGY INHIBITORS AND THERAPEUTIC USES THEREOF”. With publication no. WO/2026/148266, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/13

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....